Antibody-mediated cytotoxicity is a process whereby nonimmune lymphocytes damage or destroy target cells in the presence of antibody to the target cell (Perlmann and Holm, 1969; MacLennan et al., 1970) . Reduced cytotoxic activity has been shown in systemic lupus erythematosus (Schneider et al., 1975) . We have measured the cytotoxic activity of peripheral blood and synovial fluid lymphocytes of patients with rheumatoid arthritis.
Materials and methods
Seventy patients (22 males, 48 females) with classical or definite rheumatoid arthritis (RA) by the ARA criteria (Committee of the American Rheumatism Association, 1959) were studied. Their ages ranged from 18-70 years, mean 52 years. The majority were taking 2-4 g aspirin daily. 10 patients were taking up to 10 mg prednisolone daily and 17 patients 250 mg chloroquine phosphate daily. Disease activity was assessed by clinical examination and designated as very active, moderately active, or inactive. On the day of the study the erythrocyte sedimentation rate was measured (Westergren) and the serum tested for the presence of rheumatoid factor (Ball, 1950) . Synovial fluid samples were obtained from 10 patients by needle aspiration. Control subjects consisted of 15 patients with osteoarthrosis and 15 healthy volunteers matched approximately for age and sex with the RA patients.
Test system
The method used was that described by Calder et al. (1974) combination of these drugs. The degree of cytotoxicity did not correlate with the age of patient or the duration of the disease.
Discussion
We have found that the cytotoxic activity of peripheral blood lymphocytes from patients with seropositive RA is reduced compared with that of patients with seronegative disease and control subjects. There seems to be a relationship between the activity of the disease and the cytotoxic activity. Patients with very active disease have poor cytotoxic activity and patients with minimally active disease have normal cytotoxic activity. Synovial fluid lymphocytes are also poorly cytotoxic.
Interpretation of the cause and significance of a reduction in cytotoxic activity is limited to some extent because the effector cell has not been precisely identified and its biological role in vivo has not been clearly defined. Nevertheless, the following explanations of the defective cytotoxic activity observed in the study are worth considering.
In We favour an alternative theory, namely that the cytotoxic cells are present in normal numbers but have been rerdered functionally ineffective by a factor present both in the synovial fluid and in the circulation of patients with active disease. Immunoglobulin complexes might be responsible. The cytotoxic reaction seems to depend on the union of immunoglobulin on the surface of the target cell with the Fc receptor of the effector cell. Aggregated IgG blocks this reaction (Calder et al., 1974) . Immunoglobulin complexes might also block the reaction by competing with the target cell immunoglobulin for the Fc receptor of the effector cell.
Inmmunoglobulin complexes have been shown in the synovial fluid and serum of patients with RA (Wirichester et al., 1971) . Serum from some patients with RA has been shown to inhibit cytotoxic activity (Barriett and MacLennan, 1972) . In our study the cytotoxicity of the peripheral blood lymphocytes was reduced during phases of increased disease activity, that is, at a time when circulating immunoglobulin complexes are most likely to be present. 
